论文部分内容阅读
目的:支气管哮喘病的疗效,将两种用药方式对比,即:孟鲁司特纳与布地奈德合用和其中一种药物单用。方法:不分条件地抽出60名病人,都患有支气管哮喘病。将其均分,各自为:观察组与对照组,分别30名患者。其中观察组选择两种药物合用的方法,对照组则采用单一药物治疗法。实验时间为一周,分别观察两组病人的疾病治疗情况,具体从病症恢复程度、肺功能等。结果:经对比,两种治疗方法有着较大的差距,主要从患者的整体症状、哮喘发作次数等方面进行观察,经观察,采用药物联合治疗的小组效果更好,二者对比有显著差异,P<0.05,有统计学意义。结论:通过药物联合治疗,能够更好地治疗支气管哮喘病。
OBJECTIVE: To evaluate the efficacy of bronchial asthma by comparing two modes of administration: montelukastina in combination with budesonide and one of these drugs alone. Methods: Sixty patients were extracted without any conditions and both had bronchial asthma. The average was divided into: observation group and control group, respectively, 30 patients. The observation group chose the combination of two drugs, while the control group used single drug therapy. The experimental time was one week, and the disease treatment status of two groups of patients was observed respectively, specifically from the degree of recovery of the disease and lung function. Results: After the comparison, the two treatment methods have a big gap, mainly from the patient’s overall symptoms, the number of asthma attacks and other aspects of observation, the use of drug combination group was better, the two were significantly different, P <0.05, with statistical significance. Conclusions: Bronchial asthma can be better treated by combination therapy.